drugset / Trial / NCT01676493

A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain

NCT01676493

Phase 3 Terminated 31 enrolled Roxane Laboratories Quintiles, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a multicenter, open-label study to evaluate the safety and PK of oral codeine sulfate in pediatric subjects with mild to moderate post-procedural pain.

Timeline

Start
2012-04
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Codeine Small molecule Oral

Indications

No indication recorded.